Skip To Main Content
Wayne H.-H on Muck Rack

Wayne H.-H

As seen in: Biomed Central (BMC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Wayne H.-H’s profile

Articles by Wayne H.-H

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia (

|
By Elise Chia-Hui, Dae Gyo Jung, Wayne H.-H, Kyoung Hwa
| paperity.org
Cardiovascular Diabetology, Aug 2023 Studies that have reported lower risk for cardiovascular outcomes in users of Sodium–Glucose Cotransporter-2 Inhibitors (SGLT-2i) are limited by residual cofounding and lack of information on prior cardiovascular disease (CVD).
Open in Who Shared Issue with article?

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia |

|
By Dae Gyo Jung, Kyoung Hwa, Elise Chia-Hui, Wayne H.-H
| Biomed Central (BMC)
References Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881–90. Article PubMed Google Scholar Kang YM, Kim YJ, Park JY, Lee WJ, Jung CH. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol. 2016;15(1):131. Article PubMed PubMed Central Google Scholar Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al.
Open in Who Shared Issue with article?
Show More